INSIGHTS ON CLINICAL TRIAL DESIGN
-
![GettyImages-547131922 research, regulatory, lab]( "Market Approval For A Novel Non-Hodgkin Lymphoma (NHL) Therapy")
Market Approval For A Novel Non-Hodgkin Lymphoma (NHL) TherapyExplore a collaboration that underscores the importance of strategic planning and regulatory engagement in the approval process.
-
![Parexel_PaidADs_HighRes]( "Navigating The Challenges Of Large, International Phase III Breast Cancer Trials")
Navigating The Challenges Of Large, International Phase III Breast Cancer TrialsIn the competitive landscape of breast cancer research, aligning biomarker testing, regulatory pathways, and regional operations from day one creates a path to faster enrollment and stronger outcomes.
-
![Pharmacy Considerations For Early Phase Trials]( "Pharmacy Considerations For Early Phase Trials")
Pharmacy Considerations For Early Phase TrialsThis presentation explores practical pharmacy considerations in early-phase clinical trials, offering real-world insights from experienced clinical research pharmacists.
-
![smartSelect]( "Investigator SmartSelect")
Investigator SmartSelectThis advanced recommendation engine identifies protocol-specific investigators in just minutes, dramatically shortening a process that typically takes four to six weeks.
-
4 Core Biomarker-Driven Study Designs In Oncology2/19/2026
Modern oncology demands smarter trial designs. Explore how enrichment, stratification, and basket models transform biomarker data into successful, regulatory-ready clinical programs.
-
5 Common Gaps Between Patient Referral And Screening That Derail Trials6/15/2026
Up to 40% of clinical trial referrals drop off before screening due to financial, logistical, and administrative hurdles. Streamlining coordination and easing patient burden can boost enrollment.
-
Five Predictions For Clinical Research In 20252/19/2025
In 2025, AI-powered adaptive protocols will redefine study design, shifting the industry from rigid, pre-planned models to flexible, real-world-optimized trials.
-
Why Mobile Eye Exams Are Critical In Clinical Trials With Ocular Endpoints1/29/2025
Explore how mobile eye exams can expand access to eye care and improve the geographical reach of clinical trials.
-
Why Early RTSM Involvement Matters3/25/2026
Early stakeholder involvement helps spot protocol and logistical misalignments before they become operational issues, strengthening RTSM readiness and reducing activation delays.
CLINICAL TRIAL DESIGN SOLUTIONS
-
![GettyImages-953449116 clinical trial oversight]( "Smarter Oversight, Earlier Action")
When risk-based oversight is reduced to a compliance checkbox, critical signals can be missed and escalate into systemic issues.
-
![Couple driving in car-GettyImages-1320539830]( "Integrating Lyft Pass To Increase Flexibility For Trial Participants")
Whether used for routine appointments or trial participation, Lyft Pass ensures that patients have timely access to transportation, supporting adherence to schedules and improving overall engagement.
-
![GettyImages-1219551222-Patient-Person-Recruitment-Select]( "Accelerate Enrollment And Reduce Site Burden")
Driven by AI and real-world data, Citeline PatientMatch helps sponsors identify highly qualified, protocol-matched patients earlier in their care journey — when enrollment decisions matter most.
-
![Clinical Trials]( "TrialScope Disclose")
With TrialScope Disclose, study sponsors streamline and optimize the entire clinical trial disclosure process from initial registration to final results — mitigating risk, maximizing transparency and ultimately moving healthcare forward.
-
![clinical-trials-patients-GettyImages-1629549075]( "An Experienced Endocrinology And Metabolic Partner")
Accelerate endocrinology and metabolic trials. Discover global regulatory strategies, decentralized models, and patient-centric recruitment data to optimize your clinical development.
